Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 1—January 2011

Dispatch

Serologic Status for Pandemic (H1N1) 2009 Virus, Taiwan

Daniel Tsung-Ning Huang1, Pei-Lan Shao1, Kuo-Chin Huang, Chun-Yi Lu, Jen-Ren Wang, Shin-Ru Shih, Hsin Chi, Mei-Ru Lai, Chin-Yun Lee, Luan-Yin Chang, and Li-Min HuangComments to Author 
Author affiliations: Author affiliations: Mackay Memorial Hospital, Taipei, Taiwan (D.T.-N. Huang, H. Chi); National Taiwan University Hospital, Taipei (P.-L. Shao, K.-C. Huang, C.-Y. Lu, M.-R. Lai, C.-Y. Lee, L.-Y. Chang, L.-M. Huang); National Cheng Kung University, Tainan, Taiwan (J.-R. Wang); Chang-Gung Memorial Hospital, Taipei (S.-R. Shih); National Taiwan University, Taipei (L.-M. Huang)

Main Article

Figure

Seroprotection rates determined by hemagglutination inhibition (HI) assay (white bars) or microneutralization (MN) assay (gray bars) and geometric mean titer (GMT) of antibodies against pandemic (H1N1) 2009 virus in each 10-year age cohort, Taiwan, 2007–2008.

Figure. Seroprotection rates determined by hemagglutination inhibition (HI) assay (white bars) or microneutralization (MN) assay (gray bars) and geometric mean titer (GMT) of antibodies against pandemic (H1N1) 2009 virus in each 10-year age cohort, Taiwan, 2007–2008.

Main Article

1These authors contributed equally to this article.

TOP